Occult HBV infection and archived resistance to 3TC could predict virological failure during 3TC/DTG maintenance antiretroviral therapy: a retrospective study
Risk of Hepatitis B reactivation in people with HIV (PWH) with isolated anti-core antibody (HBcAb) after switch to 2DR strategies with lamivudine(3TC)/dolutegravir(DTG)
Heterogeneity in the diagnostic sensitivities of HDV RNA quantification assays used in clinical practice in Italy: data from the first national quality control multicenter study